A phase 1b/2 study of ribociclib plus trastuzumab for the treatment of advanced, treatment-refractory HER2-positive breast cancerS. Goel,L. Spring,R. Rees, C. Andrews, R. K. Tahara,E. L. Mayer,A. Bardia,E. P. Winer, S. M. TolaneyCANCER RESEARCH(2019)引用 2|浏览17暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要